Show
Sort by
-
Current practice of gastro-intestinal endoscopy in children in Belgium
-
- Journal Article
- A1
- open access
The importance of detecting anti-DFS70 in routine clinical practice : comparison of different care settings
-
Long-term outcomes with anti-TNF therapy and accelerated step-up in the prospective pediatric Belgian Crohnʼs disease registry (BELCRO)
-
Paediatric Crohn's disease : disease activity and growth in the BELCRO cohort after 3 years follow-up
-
Aeromonas species : an opportunistic enteropathogen in patients with inflammatory bowel diseases? A single center cohort study
-
Longterm followup of rituximab therapy in patients with rheumatoid arthritis: results from the Belgian MabThera in Rheumatoid Arthritis registry
-
The Belgian registry of pediatric Crohn's disease (BELCRO): growth status after 3 year follow up
-
Disease severity after 3 years of treating newly diagnosed pediatric Crohn's disease patients (The Belcro cohort)
-
Pediatric Crohn’s disease: a different approach between pediatric and adult gastroenterologists?
-
Misdiagnosis as asphyxiating thoracic dystrophy and CMV-associated haemophagocytic lymphohistiocytosis in Shwachman-Diamond syndrome
-
Three-year follow-up of rituximab in rheumatoid arthritis: results from the Belgian MIRA (MabThera in Rheumatoid Arthritis) registry
-
Gastrointestinal problems in children with Down syndrome
-
- Journal Article
- A1
- open access
Portal hypertension after combined liver and intestinal transplantation, a diagnostic and therapeutic challenge?
-
Factors determining therapeutic strategy at diagnosis and evolution of disease severity in a cohort of Belgian pediatric Crohn's disease patients (BELCRO)
-
Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease
-
Profile of Belgian pediatric CD patients : presentation and diagnostic features
-
Profile of Belgian pediatric CD patients : associations between variables at diagnosis
-
- Journal Article
- A1
- open access
The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies
-
Sensitivity and specificity of criteria for spondyloarthritis in children with late onset pauciarticular juvenile chronic arthritis as well as their characteristics
-
Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease
-
Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis
-
Infliximab does not increase short-term post-operative infectious complications in patients with ulcerative colitis
-
Long-term outcome after infliximab for refractory ulcerative colitis
-
Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope
-
Modeling the probability for rheumatoid arthritis during diagnostic work-up: How to combine the results of ACPA, RF and HLA-SE testing?
-
Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis
-
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus - An international meta-analysis
-
Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
-
Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relation with rheumatoid factor
-
Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry
-
Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years
-
Case number 34: Relapse of polyarteritis nodosa presenting as isolated and localised lower limb periostitis
-
Mannose-binding lectin (Mbl2) polymorphisms in rheumatoid arthritis are not associated with susceptibility, radiological progression rate, or serological markers
-
Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis
-
Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus
-
CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients
-
Diagnostic performance and predictive value of rheumatoid factor, anti-citrullinated peptide antibodies, and the HLA shared epitope for diagnosis of rheumatoid arthritis
-
Physiological levels of hydrocortisone maintain an optimal chondrocyte extracellular matrix metabolism
-
Building decision tree classifiers using a Kohonen self-organizing map
-
Weight analysis of a topological map to determine parameter importance
-
Prediction of arthritis using a modified Kohonen mapping and case based reasoning
-
Prediction of diagnosis in patients with early arthritis using a combined Kohonen mapping and instance-based evaluation criterion
-
History and diagnostic value of antibodies to citrullinated proteins in rheumatoid arthritis
-
Identification of synovial histopathological parameters for diagnostic classification of inflammatory arthritis by SAM analysis and neural networks
-
Protein expression profiling of inflamed synovial tissue in rheumatoid arthritis, spondyloarthropathy and osteoarthritis
-
The presence of CARD15 polymorphisms is linked with higher ASCA titers in Crohn's disease
-
Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology - A prospective study in 154 consecutive patients
-
Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus
-
Diagnostic performance and predictive value of serum markers for the diagnosis of rheumatoid arthritis
-
False positivity of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus
-
Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations
-
Combined impact of mucosal damage and of cystic fibrosis on the small intestinal brush border enzyme activities
-
The use of neural network algorithms for the classification of undifferentiated arthritis by synovial histopathology
-
Prediction of arthritis using a modified Kohonen mapping and case based learning
-
The use of neural network algorithms for the classification of undifferentiated arthritis by synovial histopathology
-
Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy
-
Changes in rheumatoid factor reflect the inflammatory response (CRP and ESR) to infliximab treatment
-
The diagnostic value of synovial histopathology in undifferentiated inflammatory arthritis: a prospective study in 154 consecutive patients
-
Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy
-
Rheumatoid factor and anti-citrullinated peptide antibodies in rheumatoid arthritis: Diagnostic value and association with radiological progression
-
Association between ASCA-positivity and carrier of a CARD-15 mutation in patients with Crohn's disease
-
Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests.
-
Extra-intestinal manifestations of enteropathies : why are the joints involved?
-
Prediction of diagnosis in patients with early arthritis using a modified Kohonen mapping in combination with a case based learning evaluation criterion